Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $607.4800 (-1.1%) ($607.4800 - $607.4800) on Wed. Jun. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.84% (three month average) | RSI | 35 | Latest Price | $607.4800(-1.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.6% a day on average for past five trading days. | Weekly Trend | REGN declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(38%) IWD(36%) SPLV(35%) SPY(35%) | Factors Impacting REGN price | REGN will decline at least -0.92% in a week (0% probabilities). VIXM(-13%) TBT(-12%) UUP(-6%) VXX(-2%) USO(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.92% (StdDev 1.84%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $651.69 | 5 Day Moving Average | $618.39(-1.76%) | 10 Day Moving Average | $646.32(-6.01%) | 20 Day Moving Average | $651.69(-6.78%) | To recent high | -17.8% | To recent low | 1.2% | Market Cap | $64.41b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |